Nisa Investment Advisors’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $259K | Buy |
3,310
+375
| +13% | +$25.6K | ﹤0.01% | 1167 |
|
|
2026
Q1 | $190K | Sell |
2,935
-83
| -3% | -$5.85K | ﹤0.01% | 1226 |
|
|
2025
Q4 | $203K | Sell |
3,018
-1,649
| -35% | -$111K | ﹤0.01% | 1230 |
|
|
2025
Q3 | $342K | Sell |
4,667
-19
| -0.4% | -$1.26K | ﹤0.01% | 1128 |
|
|
2025
Q2 | $244K | Sell |
4,686
-925
| -16% | -$52.6K | ﹤0.01% | 1170 |
|
|
2025
Q1 | $358K | Buy |
5,611
+215
| +4% | +$12.5K | ﹤0.01% | 1081 |
|
|
2024
Q4 | $258K | Sell |
5,396
-99
| -2% | -$5.08K | ﹤0.01% | 1222 |
|
|
2024
Q3 | $315K | Buy |
5,495
+1,358
| +33% | +$77.9K | ﹤0.01% | 1174 |
|
|
2024
Q2 | $217K | Buy |
4,137
+107
| +3% | +$4.69K | ﹤0.01% | 1289 |
|
|
2024
Q1 | $164K | Buy |
4,030
+79
| +2% | +$2.96K | ﹤0.01% | 1354 |
|
|
2023
Q4 | $146K | Sell |
3,951
-1,894
| -32% | -$71.3K | ﹤0.01% | 1354 |
|
|
2023
Q3 | $223K | Sell |
5,845
-29
| -0.5% | -$1.19K | ﹤0.01% | 1281 |
|
|
2023
Q2 | $212K | Buy |
5,874
+281
| +5% | +$9.59K | ﹤0.01% | 1317 |
|
|
2023
Q1 | $214K | Sell |
5,593
-1,130
| -17% | -$53K | ﹤0.01% | 1298 |
|
|
2022
Q4 | $383K | Hold |
6,723
| – | – | ﹤0.01% | 1195 |
|
|
2022
Q3 | $300K | Sell |
6,723
-68
| -1% | -$3.01K | ﹤0.01% | 1176 |
|
|
2022
Q2 | $299K | Hold |
6,791
| – | – | ﹤0.01% | 1201 |
|
|
2022
Q1 | $271K | Buy |
6,791
+1,020
| +18% | +$36.3K | ﹤0.01% | 1261 |
|
|
2021
Q4 | $200K | Sell |
5,771
-239
| -4% | -$8.92K | ﹤0.01% | 1268 |
|
|
2021
Q3 | $244K | Sell |
6,010
-5,027
| -46% | -$210K | ﹤0.01% | 1335 |
|
|
2021
Q2 | $501K | Hold |
11,037
| – | – | ﹤0.01% | 1140 |
|
|
2021
Q1 | $460K | Hold |
11,037
| – | – | ﹤0.01% | 1189 |
|
|
2020
Q4 | $471K | Buy |
11,037
+3,624
| +49% | +$130K | ﹤0.01% | 1177 |
|
|
2020
Q3 | $195K | Sell |
7,413
-8,154
| -52% | -$227K | ﹤0.01% | 1318 |
|
|
2020
Q2 | $417K | Buy |
15,567
+3,347
| +27% | +$75.5K | ﹤0.01% | 1080 |
|
|
2020
Q1 | $220K | Sell |
12,220
-5,930
| -33% | -$113K | ﹤0.01% | 1167 |
|
|
2019
Q4 | $322K | Buy |
18,150
+1,120
| +7% | +$19.4K | ﹤0.01% | 1215 |
|
|
2019
Q3 | $264K | Buy |
17,030
+11,400
| +202% | +$188K | ﹤0.01% | 1258 |
|
|
2019
Q2 | $97K | Hold |
5,630
| – | – | ﹤0.01% | 1423 |
|
|
2019
Q1 | $91K | Hold |
5,630
| – | – | ﹤0.01% | 1450 |
|
|
2018
Q4 | $82K | Hold |
5,630
| – | – | ﹤0.01% | 1383 |
|
|
2018
Q3 | $102K | Sell |
5,630
-140
| -2% | -$2.45K | ﹤0.01% | 1393 |
|
|
2018
Q2 | $97K | Hold |
5,770
| – | – | ﹤0.01% | 1367 |
|
|
2018
Q1 | $113K | Sell |
5,770
-350
| -6% | -$6.78K | ﹤0.01% | 1332 |
|
|
2017
Q4 | $124K | Hold |
6,120
| – | – | ﹤0.01% | 1345 |
|
|
2017
Q3 | $106K | Hold |
6,120
| – | – | ﹤0.01% | 1359 |
|
|
2017
Q2 | $78K | Hold |
6,120
| – | – | ﹤0.01% | 1376 |
|
|
2017
Q1 | $79K | Sell |
6,120
-980
| -14% | -$12.4K | ﹤0.01% | 1390 |
|
|
2016
Q4 | $70K | Buy |
7,100
+5,000
| +238% | +$54.8K | ﹤0.01% | 1386 |
|
|
2016
Q3 | $25K | Buy |
2,100
+1,200
| +133% | +$12.3K | ﹤0.01% | 1577 |
|
|
2016
Q2 | $8K | Hold |
900
| – | – | ﹤0.01% | 1810 |
|
|
2016
Q1 | $9K | Buy |
+900
| New | +$8.47K | ﹤0.01% | 1787 |
|
Other funds holding HALO
Nisa Investment Advisors's HALO Position: Q2 2026 in Review
Nisa Investment Advisors increased its Halozyme (HALO) stake by 13% in Q2 2026, buying an estimated $25.6K and bringing the position to 3,310 shares worth $259K. The position accounts for ﹤0.01% of the portfolio, ranked #1167.
Nisa Investment Advisors first reported a position in HALO in Q1 2016 and has held it in 42 quarters since. The position peaked at $501K in Q2 2021. 673 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Nisa Investment Advisors held 3,310 shares of Halozyme worth $259K as of Q2 2026.
- Nisa Investment Advisors bought 375 Halozyme shares in Q2 2026, an estimated $25.6K.
- Halozyme made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1167 holding.
- Nisa Investment Advisors first reported a position in Halozyme in Q1 2016 and has held it in 42 quarters since.
- Nisa Investment Advisors's Halozyme position peaked at $501K in Q2 2021.
- 673 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.